Gyungyub Gong

Gyungyub Gong

Auto-generated profile, based on publicly available information

Gyungyub Gong

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2009 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
EKEui Young Kim
Eui Young Kim
WKWon Gu Kim
Won Gu Kim
WKWon Gu Kim
Won Gu Kim
TKTae Hyuk Kim
Tae Hyuk Kim
JKJung Min Kim
Jung Min Kim
YSYoung Kee Shong
Young Kee Shong

1 August 2015 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
HLHee Jin Lee
Hee Jin Lee
JKJoo Young Kim
Joo Young Kim
IPIn Ah Park
In Ah Park
ISIn Hye Song
In Hye Song
JYJong Han Yu
Jong Han Yu
GGGyungyub Gong
Gyungyub Gong
Objectives: Tumor-infiltrating lymphocytes (TILs) have prognostic significance in breast cancer. The tertiary lymphoid structure (TLS) is related to the influx of TILs, and expression of major histocompatibility complex (MHC) I in tumor cells is necessary for the effective action of TILs. Methods: We retrospectively evaluated the relationship of TILs and TLS and the expression of MHC I in 447 HER2-positive breast cancers treated with chemotherapy and 1 year of trastuzumab. Results: TILs were more abundant in hormone receptor (HR)−/HER2+ tumors than in HR+/HER2+ tumors. HR−/HER2+ breast cancers with abundant TILs showed a higher histologic grade, the absence of lymphovascular invasion, the presence of peritumoral lymphocytic infiltration, moderate to abundant TLSs in adjacent tissue, and stronger HLA-ABC and HLA-A expression. Abundant TILs and the absence of lymphovascular invasion were found to be good, independent prognostic factors for disease-free survival in patients with HR−/HER2+ breast cancer. The level of TILs was not associated with the patients’ prognosis in HR+ tumors. Conclusions: Abundant TILs are an independent prognostic factor in HR−/HER2+ breast cancers. Evaluation of TILs in HR−/HER2+ breast cancers may provide valuable information regarding the prognosis of patients treated using adjuvant chemotherapy and trastuzumab.

1 January 2013 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
HLHee Jin Lee
Hee Jin Lee
JSJin-Young Seo
Jin-Young Seo
JAJin-Hee Ahn
Jin-Hee Ahn
SASei-Hyun Ahn
Sei-Hyun Ahn
GGGyungyub Gong
Gyungyub Gong
Lee HJ, et al. J Breast Cancer. 2013 Mar;16(1):32-39. http://dx.doi.org/10.4048/jbc.2013.16.1.32

1 January 2019 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
MLMiseon Lee
Miseon Lee
SHSun-Hee Heo
Sun-Hee Heo
ISIn Hye Song
In Hye Song
HRHajar Rajayi
Hajar Rajayi
HPHye Seon Park
Hye Seon Park
HLHee Jin Lee
Hee Jin Lee

6 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HLHee Jin Lee
Hee Jin Lee
YKYoung-Ae Kim
Young-Ae Kim
CSChan Kyu Sim
Chan Kyu Sim
SHSun-Hee Heo
Sun-Hee Heo
ISIn Hye Song
In Hye Song
GGGyungyub Gong
Gyungyub Gong
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer

18 April 2016 in Oncotarget
Verified
Journal Article
Open access
HLHee Jin Lee
Hee Jin Lee
ISIn Hye Song
In Hye Song
IPIn Ah Park
In Ah Park
SHSun-Hee Heo
Sun-Hee Heo
YKYoung-Ae Kim
Young-Ae Kim
GGGyungyub Gong
Gyungyub Gong
Tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC) have a strong prognostic and predictive significance. However, the mechanism of TIL influx in TNBC is unclear. Expression of major histocompatibility complex class I (MHC I) on the tumor cell is essential for the effective killing of tumor by cytotoxic TILs. In our current study, human leukocyte antigen (HLA) expression was inversely correlated with estrogen receptor (ER) expression in normal and cancerous breast tissue and positively correlated with TILs in breast cancer. The ER score was inversely correlated with TILs in breast cancer. HLA-A and CD8B gene expression was negatively correlated with ESR1 and positively correlated with interferon-associated gene expression in The Cancer Genome Atlas (TCGA) data. Negative correlation between ESR1 and HLA and positive correlation between interferon-associated and HLA gene expression were also confirmed in Cancer Cell Line Encyclopedia (CCLE) data. Taken together, our data suggest that a lower expression of HLA in luminal-type tumors might be associated with low level of TILs in those tumors. Further investigation of the mechanism of higher HLA expression and TIL influx in TNBC may help to boost the host immune response.